+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Adaptive Biotechnologies Corp (ADPT) - Product Pipeline Analysis, 2021 Update

  • ID: 5519788
  • Company Profile
  • December 2021
  • 44 Pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • 10X Genomics Inc
  • bluebird bio Inc
  • Epic Sciences Inc
  • Eureka Therapeutics Inc
  • Illumina Inc
  • Krystal Biotech Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Adaptive Biotechnologies Corp (Adaptive) is a developer of immune-driven medicine. Its products include immunoSEQ and clonoSEQ. The company provides immune-sequencing platform to laboratories for conducting research in the areas of oncology and other immune-mediated diseases, and TCR screening for the development of vaccines. Adaptive develops assays for both clinical diagnosis and therapeutic monitoring for a variety of disorders and conditions. It specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company translates immune-sequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. It works in partnership with institutions and biopharmaceutical companies. The company has offices in South San Francisco, San Diego and New York. Adaptive is headquartered in Seattle, Washington, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Adaptive Biotechnologies Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:


  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 10X Genomics Inc
  • bluebird bio Inc
  • Epic Sciences Inc
  • Eureka Therapeutics Inc
  • Illumina Inc
  • Krystal Biotech Inc
  • Adaptive Biotechnologies Corp Company Overview
  • Adaptive Biotechnologies Corp Company Snapshot
  • Adaptive Biotechnologies Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Adaptive Biotechnologies Corp - Pipeline Analysis Overview
  • Adaptive Biotechnologies Corp - Key Facts
  • Adaptive Biotechnologies Corp - Major Products and Services
  • Adaptive Biotechnologies Corp Pipeline Products by Development Stage
  • Adaptive Biotechnologies Corp Pipeline Products Overview
  • Anti-TNF Response Test - Crohn’s Disease
  • Anti-TNF Response Test - Crohn’s Disease Product Overview
  • ClonoSEQ Assay - ALL
  • ClonoSEQ Assay - ALL Product Overview
  • ClonoSEQ Assay - Non-Hodgkin’s Lymphoma
  • ClonoSEQ Assay - Non-Hodgkin’s Lymphoma Product Overview
  • Companion Diagnostic Test - Melanoma Cancer
  • Companion Diagnostic Test - Melanoma Cancer Product Overview
  • Diagnostic Assay - Cutaneous T-Cell Lymphoma
  • Diagnostic Assay - Cutaneous T-Cell Lymphoma Product Overview
  • Diagnostic Test - Infection
  • Diagnostic Test - Infection Product Overview
  • Immune System Profiling - Measure Of Vaccine Efficacy
  • Immune System Profiling - Measure Of Vaccine Efficacy Product Overview
  • immunoSEQ Assay - Post-Transplant
  • immunoSEQ Assay - Post-Transplant Product Overview
  • ImmunoSEQ Dx - Celiac Disease
  • ImmunoSEQ Dx - Celiac Disease Product Overview
  • ImmunoSEQ Dx - Lyme Disease
  • ImmunoSEQ Dx - Lyme Disease Product Overview
  • ImmunoSEQ Dx - Ovarian Cancer
  • ImmunoSEQ Dx - Ovarian Cancer Product Overview
  • Non-Invasive Diagnostic Test - Celiac Disease
  • Non-Invasive Diagnostic Test - Celiac Disease Product Overview
  • Pre - Symptomatic Biomarker - Type 1 Diabetes
  • Pre - Symptomatic Biomarker - Type 1 Diabetes Product Overview
  • Prediction Of Active Disease State - Crohn's Disease
  • Prediction Of Active Disease State - Crohn's Disease Product Overview
  • T-Detect - Celiac Disease
  • T-Detect - Celiac Disease Product Overview
  • T-Detect - Crohn’s Disease
  • T-Detect - Crohn’s Disease Product Overview
  • T-Detect - Lyme Disease
  • T-Detect - Lyme Disease Product Overview
  • T-Detect - Ovarian Cancer
  • T-Detect - Ovarian Cancer Product Overview
  • tilSEQ Assay
  • tilSEQ Assay Product Overview
  • Adaptive Biotechnologies Corp - Key Competitors
  • Adaptive Biotechnologies Corp - Key Employees
  • Adaptive Biotechnologies Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Recent Developments
  • Adaptive Biotechnologies Corp, Recent Developments
Nov 03, 2021: Adaptive Biotechnologies Reports Third Quarter 2021 Financial Results
Oct 06, 2021: Adaptive Biotechnologies to Report Third Quarter Financial Results on November 3, 2021
Oct 02, 2021: Adaptive Biotechnologies presents new data during IDWeek demonstrating the capability of its immune medicine platform to distinguish between SARS-CoV-2 infection and vaccine response and detect Lyme Disease
Aug 04, 2021: Adaptive Biotechnologies Reports Second Quarter 2021 Financial Results
Aug 04, 2021: Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer
May 20, 2021: Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Conferences
May 05, 2021: Adaptive Biotechnologies Reports First Quarter 2021 Financial Results
Apr 12, 2021: Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021
Mar 17, 2021: Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen
Feb 02, 2021: Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

Appendix
  • Methodology
  • About The Publisher
  • Contact The Publisher
  • Disclaimer

List of Tables
  • Adaptive Biotechnologies Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Adaptive Biotechnologies Corp Pipeline Products by Equipment Type
  • Adaptive Biotechnologies Corp Pipeline Products by Indication
  • Adaptive Biotechnologies Corp, Key Facts
  • Adaptive Biotechnologies Corp, Major Products and Services
  • Adaptive Biotechnologies Corp Number of Pipeline Products by Development Stage
  • Adaptive Biotechnologies Corp Pipeline Products Summary by Development Stage
  • Anti-TNF Response Test - Crohn’s Disease - Product Status
  • Anti-TNF Response Test - Crohn’s Disease - Product Description
  • ClonoSEQ Assay - ALL - Product Status
  • ClonoSEQ Assay - ALL - Product Description
  • ClonoSEQ Assay - Non-Hodgkin’s Lymphoma - Product Status
  • ClonoSEQ Assay - Non-Hodgkin’s Lymphoma - Product Description
  • Companion Diagnostic Test - Melanoma Cancer - Product Status
  • Companion Diagnostic Test - Melanoma Cancer - Product Description
  • Diagnostic Assay - Cutaneous T-Cell Lymphoma - Product Status
  • Diagnostic Assay - Cutaneous T-Cell Lymphoma - Product Description
  • Diagnostic Test - Infection - Product Status
  • Diagnostic Test - Infection - Product Description
  • Immune System Profiling - Measure Of Vaccine Efficacy - Product Status
  • Immune System Profiling - Measure Of Vaccine Efficacy - Product Description
  • immunoSEQ Assay - Post-Transplant - Product Status
  • immunoSEQ Assay - Post-Transplant - Product Description
  • ImmunoSEQ Dx - Celiac Disease - Product Status
  • ImmunoSEQ Dx - Celiac Disease - Product Description
  • ImmunoSEQ Dx - Lyme Disease - Product Status
  • ImmunoSEQ Dx - Lyme Disease - Product Description
  • ImmunoSEQ Dx - Ovarian Cancer - Product Status
  • ImmunoSEQ Dx - Ovarian Cancer - Product Description
  • Non-Invasive Diagnostic Test - Celiac Disease - Product Status
  • Non-Invasive Diagnostic Test - Celiac Disease - Product Description
  • Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Status
  • Pre - Symptomatic Biomarker - Type 1 Diabetes - Product Description
  • Prediction Of Active Disease State - Crohn's Disease - Product Status
  • Prediction Of Active Disease State - Crohn's Disease - Product Description
  • T-Detect - Celiac Disease - Product Status
  • T-Detect - Celiac Disease - Product Description
  • T-Detect - Crohn’s Disease - Product Status
  • T-Detect - Crohn’s Disease - Product Description
  • T-Detect - Lyme Disease - Product Status
  • T-Detect - Lyme Disease - Product Description
  • T-Detect - Ovarian Cancer - Product Status
  • T-Detect - Ovarian Cancer - Product Description
  • tilSEQ Assay - Product Status
  • tilSEQ Assay - Product Description
  • Adaptive Biotechnologies Corp, Key Employees
  • Adaptive Biotechnologies Corp, Other Locations
  • Glossary

List of Figures
  • Adaptive Biotechnologies Corp Pipeline Products by Equipment Type
  • Adaptive Biotechnologies Corp Pipeline Products by Development Stage
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • bluebird bio Inc
  • Eureka Therapeutics Inc
  • 10X Genomics Inc
  • Illumina Inc
  • Epic Sciences Inc
  • Natera Inc
  • MIODx
  • Krystal Biotech Inc
Note: Product cover images may vary from those shown